ARCHIVES

Xgeva Delays Metastases To Bone, Amgen Files To Expand Indication

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

Varmus: NCI Needs To Rethink, Review; Programs Must Be “At A High Level”

November 12, 2010

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

November 26, 2014

Frozen Serum Panels Available For Assays

June 8, 1984

HER2+ Tumors Increase Risk Of Recurrence, Study Finds

November 27, 2009

Bevacizumab Prolongs Survival In Patients With Advanced Colorectal Cancer

November 26, 2004

Radiotherapy Provides Longer Life To Brain Cancer Patients

May 28, 2010